An infant with patau syndrome associated with congenital heart defects

Ubaid Khan1, Ahmad Hussain1, Muhammad Usman1

  • 1Department of Medicine, King Edward Medical University Lahore, Pakistan.

Insights

Patau syndrome, or trisomy 13, is a severe genetic condition with a poor prognosis. This case highlights common Patau syndrome features like cleft lip/palate and congenital heart defects, emphasizing the need for genetic counseling.

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Case Reports

Background:

  • Patau syndrome (trisomy 13) is a severe genetic disorder with high infant mortality.
  • The condition is characterized by multiple congenital anomalies.
  • Early diagnosis and intervention are crucial but often yield a poor prognosis.

Observation:

  • A two-day-old male infant diagnosed with Patau syndrome presented with cleft palate, cleft lip, and congenital clubfoot.
  • A pansystolic murmur indicated significant congenital heart abnormalities.
  • The infant required surgical intervention for patent ductus arteriosus (PDA), ventricular septal defect (VSD), and atrial septal defect (ASA).

Findings:

  • Consistent with Patau syndrome literature, the patient exhibited cleft lip and palate, and congenital heart defects.
  • Cardiac abnormalities, including PDA, VSD, and ASA, are frequently reported in up to 80% of trisomy 13 cases.
  • Dysmorphic features and limb impairments are characteristic manifestations.

Implications:

  • This case underscores the typical clinical presentation of Patau syndrome.
  • Highlights the critical need for early detection and management of associated cardiac defects.
  • Emphasizes the importance of genetic counseling for families affected by trisomy 13 to improve awareness and understanding of the diagnosis and its implications.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.2K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
233